Abstract
Vitamin C (L-ascorbic acid) is well known as a free radical scavenger that protects cells against damage from oxidative stress. Herein, we investigated the effects of vitamin C against diethylnitrosamine (DEN)-induced hepatotoxicity. Male wild-type (C57BL/6) and senescence marker protein-30 (Smp30) knockout (KO) mice were used and divided in the following four groups: WT group (n=15): Wild-type (WT) mice fed vitamin C-free diet with tap water; WV group (n=14): WT mice fed vitamin C-free diet with water supplemented with 1.5 g/kg vitamin C; KT group (n=12): Smp30 KO mice fed vitamin C-free diet with tap water; and KV group (n=13): Smp30 KO mice fed vitamin C-free diet with water supplemented with 1.5 g/kg vitamin C. A single intraperitoneal injection of DEN (5 mg/kg body weight) was injected in the second week during the experimental period. Mice were sacrificed after 17 weeks of treatment to investigate the effect of dietary vitamin C on DEN-induced hepatotoxicity. The results showed that vitamin C significantly increased the mean lifespan (p<0.05) in the WT, WV and KV groups compared with the KT group. The serum concentrations of γ-glutamyl transpeptidase, alanine aminotransferase, and aspartate aminotransferase did not significantly differ among groups. The WT group exhibited significantly more acute cellular swelling accompanied by centrilobular necrosis, focal lymphocyte infiltration, and eosinophilic intracytoplasmic inclusion bodies as compared with the WV and KV groups, suggesting that vitamin C had a hepatoprotective effect. Dysplastic, large, and binucleated hepatocytes were also observed in the WT group, but these pathological signs were absent from the WV and KV groups. Our experimental evidence suggests that vitamin C supplementation in Smp30 KO mice was effective for the treatment of DEN-induced hepatotoxicity.
Keywords: Vitamin C, diethylnitrosamine, hepatocellular carcinoma, Smp30 KO mice
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death, resulting in approximately 0.7 million deaths each year, and the sixth most common malignancy worldwide (1-3). The recognized risk factors for HCC are hepatic disorder associated with steatosis, cirrhosis, viral hepatitis, alcohol, chemical agents, obesity, metabolic syndrome, and so forth (4). Despite recent advances in diagnosis and treatment, the effectiveness of therapy for HCC remains unsatisfactory, and HCC has a hidden development and a poor prognosis (5,6). Therefore, there is an urgent requirement for novel therapeutic compounds for the treatment of patients with HCC. Many animal models of hepatocarcinogenesis have been established to examine the effects of therapeutic agents. Diethylnitrosamine (DEN) is frequently used as a hepatocarcinogenic agent in rodents (1). In our experimental model, externally visible foci were observed and measured by stereomicroscopy. It has been established that DEN induces HCC in animals with a developmental course similar to that of human HCC (7). Furthermore, DEN is an indirect alkylating agent that induces the generation of reactive oxygen species (ROS), which damage DNA through oxidation (8).
Senescence marker protein-30 (SMP30) is a calcium-binding protein, and its levels in the liver, kidney, and lung become significantly down-regulated with aging in an androgen-independent manner (9,10). SMP30 plays an important role in calcium (Ca2+) homeostasis (11). Ca2+ is one of the most universal and physiologically significant signaling molecules that especially affects cell apoptosis and cell necrosis (12). Other reports have indicated that SMP30 participates in controlling the activity of antioxidant enzymes (13). SMP30 protein has an activating effect on cytoplasmic superoxide dismutase in liver and heart cells (14,15). SMP30 also functions as an antioxidant protein that has a protective action against oxidative stress without influencing antioxidant enzyme expression (13). SMP30 suppresses the generation of ROS in hepatocytes (16), and decreased levels of SMP30 during aging were correlated with increased ROS generation in rat liver and kidney (17).
SMP30 is also involved in vitamin C (L-ascorbic acid) biosynthesis and catalyzes the lactonization of L-gulonic acid (9). Vitamin C is well known as a free radical scavenger that protects cells against damage caused by oxidative stress (18). Oxidative stress induces a cellular redox imbalance that is present in various cancer cells but not in normal cells; the redox imbalance thus may be related to oncogenic processes (19).
To our knowledge, no studies related to HCC have been conducted using Smp30 knockout (KO) mice, that cannot synthesize vitamin C in vivo (20). Therefore, we designed our experiment to elucidate the physiological effect of vitamin C on DEN-induced hepatocarcinogenesis in Smp30 KO mice.
Materials and Methods
Animals and chemicals. Eight- to nine-week-old male wild-type (C57BL/6) and Smp30 KO mice weighing 24-29 g were obtained from the Pathology Laboratory, College of Veterinary Medicine, Kyungpook National University, South Korea. All the experiments were carried out based on the National Institute of Health guidelines. Mice were housed in an automatically controlled environment at 22±1˚C with 55±5% relative humidity under a 12 h light/dark cycle. Vitamin C (≥98% purity) and DEN were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). All other chemicals were purchased from commercial suppliers and were of the highest grade.
Experimental procedure. Wild-type (WT) and Smp30 KO mice were divided into four different experimental groups. All the mice were intraperitoneally injected with a single dose of DEN (5 mg/kg body weight) in the second week of the 17-week experimental period. To elucidate the effect of vitamin C on the liver, the four groups were maintained for 17 weeks as follows: WT group (n=15): WT mice fed vitamin C-free diet with tap water; WV group (n=14): WT mice fed vitamin C-free diet with water supplemented with 1.5 g/kg vitamin C; KT group (n=12): Smp30 KO mice fed vitamin C-free diet with tap water; and KV group (n=13): Smp30 KO mice fed vitamin C-free diet with water supplemented with 1.5 g/kg vitamin C (Table I). All mice were sacrificed under anesthesia using ethyl ether at 17 weeks. Blood samples were collected and liver tissues were fixed in 10% neutral buffered formalin and then stored at −80˚C until analysis.
Table I. Experimental schedules. All mice were intraperitoneally injected with diethylnitrosamine (5 mg/kg) at 2 weeks.
Lifespan observation among experimental model organisms. The experimental mice were maintained for 17 weeks until sacrifice. The numbers of living mice in experimental groups were as follows: WT: n=15/15; WV: n=14/14; KT: n=1/12; and KV: n=13/13.
Biochemical analysis for the assessment of liver function. Blood samples were collected from the mice and centrifuged at 1200 × g for 20 min at 4˚C to separate the serum. The serum levels of γ-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were measured using an automated blood chemistry analyzer (7600, Hitachi, Tokyo, Japan).
Histopathological analysis. For histopathological evaluation, the liver tissues were rapidly removed, washed with cold normal saline, fixed in 10% neutral buffered formalin solution, processed routinely, dehydrated, and embedded in paraffin wax. Tissue was cut into sections of 6- to 8-μm thickness, deparaffinized, and hydrated. The liver sections were then stained with hematoxylin and eosin. Finally, hepatic pathological changes were observed and diagnosed under a microscope.
Statistical analysis. The results are presented as means±standard deviation. The data were analyzed by one-way analysis of variance followed by Dunnett’s t-test for multiple comparisons using SPSS version 12.0 (SPSS Inc., Chicago, IL, USA). The differences were considered significant at p-values of less than 0.05.
Results
Effect of vitamin C on lifespan in DEN-treated mice. In the KT group (vitamin C-deficient), only one mouse remained alive throughout the experimental period. In contrast, all mice in the WT, WV, and KV groups lived until sacrifice at the end of the experimental period (Table II). The mortality of the KT group was 91.7% (11/12), which is significantly (p0.05) higher than that of the WT, WV, and KV groups, suggesting that vitamin C has a pivotal role in the aging process. This result indicates that vitamin C supplementation may prolong lifespan (21).
Table II. Effect of vitamin C on mortality of diethylnitrosamine-treated mice .
Numbers of foci of eosinophil-related necrosis in the liver periphery. In the WT and Smp30 KO mice, we observed foci (≥0.5 mm) in the liver periphery. Therefore, microscopic foci were dissected from 6-to 8-μm-thick paraffin sections under microscopic observation. In the WT group, we observed a large number of foci in comparison to the vitamin C-supplemented WV and KV groups (data not shown). These data suggest that vitamin C protects liver cells from transformation into harmful lesions.
Effects of vitamin C on the serum concentrations of GGT, ALT, and AST in DEN-induced mice. The serum concentrations of GGT, ALT, and AST were analyzed to examine hepatic function. The results showed that the serum concentrations of GGT, ALT, and AST were similar in the KV (vitamin C-supplemented) group compared to the WT and WV (wild-type) groups. We found no significant differences in the serum concentrations of GGT, ALT, and AST among the groups (Figure 1).
Effect of vitamin C on histopathological characteristics in DEN-treated mice. In the WT group, histopathological analysis of liver tissue sections revealed severe acute cellular swelling, severe centrilobular necrosis, and some focal lymphocyte infiltrations. The WT group also showed considerable random hepatocellular degeneration as identified by cellular swelling, eosinophilic cytoplasm, and pleomorphic nuclei. In one liver section, eosinophilic intracytoplasmic inclusion bodies were observed, indicating mitochondrial damage. Contrastingly, in the KV and WV (vitamin C-supplemented) groups, such hepatic lesions were not observed. However, the WT group showed more focal lesions containing eosinophilic intracytoplasmic inclusion bodies than did the WV and KV groups. An analysis of the data suggested that vitamin C inhibited the induction of HCC by DEN in the KV and WV groups compared with the WT group (Figure 2). Dysplastic hepatocytes were identified as irregular and large hepatocytes with a large nucleus. The total number of binucleated hepatocytes was counted in each section. The number of binucleated hepatocytes was significantly higher in the WT group compared with that in the KV and WV groups (Figure 3). These data indicate that vitamin C may prevent the development of binucleated hepatocytes (22).
Discussion
HCC is one of the most frequently occurring malignancies worldwide and most HCC is complicated due to it occurring typically in patients with advanced hepatic disease (5,6,23). HCC is related to various pathogenic factors such as infection with hepatitis B virus or hepatitis C virus, chronic hepatitis, steatosis (fatty liver), liver cirrhosis and heavy alcohol consumption (4,24-26). DEN is a powerful carcinogenic agent in rodents that possibly causes its adverse effects by altering DNA structure and forming DNA adducts in the liver (8,27). The DEN-induced HCC experimental model is one of the most widely used models for screening anti-hepatocarcinogenic agents due to its similarity to human HCC (7,28). This animal model takes at least 8 months to develop typical HCC (1,29). In this study, the final stage of HCC was not detected because the experimental period was limited to 17 weeks in consideration of the short lifespan of Smp30 KO mice (30).
The SMP30 protein is responsible for the synthesis of L-gulonic acid to L-gulono-γ-lactone, the enzyme of the last step of the vitamin C conversion pathway (31-33). Therefore, Smp30 KO mice, which are unable to synthesize vitamin C, are used as a unique model to investigate the physiological functions of vitamin C in vivo (9). Vitamin C has various metabolic activities such as an antioxidant capacity that can protect cells from oxidative stress (20,34). An antioxidative property may be defined as a capacity for the scavenging of free radicals including ROS and reactive nitrogen species by donating a hydrogen or an electron (35). There have been many reports of the therapeutic or preventive efficacy of vitamin C as an anticancer agent (36,37), but no study of the DEN-induced HCC model has been conducted using congenital vitamin C-deficient Smp30 KO mice. In the present study, we investigated the impact of vitamin C supplementation on WT and Smp30 KO mice with DEN-induced HCC.
Recently, it was shown that a hepatocyte-specific deletion of either JUN gene (c-Jun) or forkhead box protein M1 (Foxm1b) in mice, which both encode transcription factors needed for hepatocyte proliferation, inhibited DEN-induced hepatocarcinogenesis (38). Thus, hepatocyte proliferation is required for DEN-induced carcinogenesis. The death of DEN-exposed hepatocytes was found to activate adjacent myeloid cells (Kupffer cells) to produce hepatomitogens that promote the proliferation of surviving hepatocytes as a compensatory effect (39).
A novel finding of this experiment is that Smp30 KO mice in the KT group (vitamin C-deficient) exhibited a significantly reduced lifespan compared with the KV, WT, and WV groups (Table II). These experimental data suggest that vitamin C is an essential compound for protection against abnormal aging (21,40-42).
We assessed the serum concentrations of GGT, ALT, and AST to investigate liver function. Our data showed that there were no significant differences among the WT, WV, and KV groups. It is unclear why the serum concentrations of GGT, ALT, and AST were similar among these groups in the present study (Figure 1).
Our histopathological analyses revealed that the WT group showed increased oxidative stress induced by DEN, that caused severe acute cellular swelling (43). We also observed necrotic hepatocytes in the WT group, which were located around the central vein and had no nuclei or faint nuclei. Most lesions except centrilobular necrosis exhibited acute cellular swelling (44). The hepatocellular degeneration was more severe in the WT group than in the KV and WV (vitamin C-supplemented) groups (Figure 2). We noticed a large number of focal lesions that were round and contained eosinophilic inclusion bodies, indicating mitochondrial damage (45). Such focal lesions are composed of pleomorphic dysplastic hepatocytes and represent an early pre-neoplastic stage (46,47).
In our study, significantly (p0.05) fewer binucleated hepatocytes were observed in the WV (vitamin C-supplemented wild-type) group and the KV (vitamin C-supplemented Smp30 KO) group compared with the WT group (Figure 3). It was reported that binucleated neuronal cells in the cortical region of the human brain in Alzheimer’s disease showed severe oxidative stress (22,48). It was demonstrated that hepatocyte binucleation is induced by an increased production of ROS, reactive nitrogen species, and other free radicals, which cause significant oxidative DNA damage in hepatic cells (8,49,50). These results show that vitamin C might attenuate DEN-induced liver toxicity (Figure 4). All these data indicate that vitamin C is a promising candidate for protecting liver cells from HCC.
In conclusion, our experimental evidence suggests that vitamin C supplementation in Smp30 KO mice was effective for the treatment of DEN-induced hepatotoxicity. More detailed studies are needed to investigate the mechanisms of action of vitamin C in reducing DEN-induced HCC.
Conflicts of interest
The Authors declare no conflict of interest.
Acknowledgements
This work was supported by the Korea Health Technology R& D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health&Welfare, Republic of Korea (grant number: HI15C0001).
References
- 1.Yamamoto M, Tanaka H, Xin B, Nishikawa Y, Yamazaki K, Shimizu K, Ogawa K. Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitro-samine in neonatal B6C3F1 mice. Mol Carcinog. 2017;56:478–488. doi: 10.1002/mc.22510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mittal S, Serag EI. Epidemiology of hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:2–6. doi: 10.1097/MCG.0b013e3182872f29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jamal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clinic. 2011;61:69–90. doi: 10.3322/caac.20107. [DOI] [PubMed] [Google Scholar]
- 4.Baffy G. Hepatocellular carcinoma in non-alcoholic fatty liver disease: epidemiology, pathogenesis, and prevention. J Clin Translat Hepatol. 2013;1:131–137. doi: 10.14218/JCTH.2013.00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol. 2015;7:1913–1920. doi: 10.4254/wjh.v7.i15.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Flores A, Marrero JA. Emerging trends in hepatocellular carcinoma:focus on diagnosis and therapeutics. Clin Med Insights Oncol. 2014;8:71–76. doi: 10.4137/CMO.S9926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Qi Y, Chen X, Chan CY, Li D, Yuan C, Yu F, Lin MC, Yew DT, Kung HF, Lai L. Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. Int J Cancer. 2008;122:2682–2688. doi: 10.1002/ijc.23464. [DOI] [PubMed] [Google Scholar]
- 8.Santos NP, Colaço A, da Costa RM, Oliveira MM, Peixoto F, Oliveira PA. N-Diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress. Exp Toxicol Pathol. 2014;66:429–436. doi: 10.1016/j.etp.2014.07.002. [DOI] [PubMed] [Google Scholar]
- 9.Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, Goto S, Nishikimi M, Maruyama N, Ishigami A. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA. 2006;103:5723–5731. doi: 10.1073/pnas.0511225103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta. 1992;1116:122–130. doi: 10.1016/0304-4165(92)90108-7. [DOI] [PubMed] [Google Scholar]
- 11.Fujita T. Senescence marker protein-30 (SMP30): Structure and biological function. Biochem Biophys Res Commun. 1999;254:1–4. doi: 10.1006/bbrc.1998.9841. [DOI] [PubMed] [Google Scholar]
- 12.Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun. 2017;482:426–431. doi: 10.1016/j.bbrc.2016.11.088. [DOI] [PubMed] [Google Scholar]
- 13.Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, Maruyama N, Lee J. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev. 2006;127:451–457. doi: 10.1016/j.mad.2006.01.005. [DOI] [PubMed] [Google Scholar]
- 14.Fukaya Y, Yamaguchi M. Regucalcin increases superoxide dismutase activity in rat liver cytosol. Biol Pharm Bull. 2004;27:1444–1450. doi: 10.1248/bpb.27.1444. [DOI] [PubMed] [Google Scholar]
- 15.Ichikawa E, Yamaguchi M. Regucalcin increases superoxide dismutase activity in the heart cytosol of normal and regucalcin transgenic rats. Int J Mol Med. 2004;14:691–696. [PubMed] [Google Scholar]
- 16.Feng D, Kondo Y, Ishigami A. Senescence marker protein 30 as a novel antiaging molecule. Ann NY Acad Sci. 2004;1019:360–364. doi: 10.1196/annals.1297.062. [DOI] [PubMed] [Google Scholar]
- 17.Jung KJ, Ishigami A, Maruyama N, Takahashi R, Goto S, Yu BP, Chung HY. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol. 2004;39:1169–1246. doi: 10.1016/j.exger.2004.04.005. [DOI] [PubMed] [Google Scholar]
- 18.Birben E, Sahiner UM, Sackesen C, Erzurum S, Katayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5:9–19. doi: 10.1097/WOX.0b013e3182439613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKβ Couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 2005;121:977–990. doi: 10.1016/j.cell.2005.04.014. [DOI] [PubMed] [Google Scholar]
- 20.Takahashi K, Kishimoto Y, Konishi T, Fujita Y, Ito M, Shimokado K, Maruyama N, Ishigami A. Ascorbic acid deficiency affects genes for oxidation–reduction and lipid metabolism in livers from Smp30/Gnl knockout mice. Biochim Biophys Acta. 2014;1840:2289–2298. doi: 10.1016/j.bbagen.2014.03.019. [DOI] [PubMed] [Google Scholar]
- 21.Conti V, Izzo V, Corbi G, Russomanno G, Manzo V, De Lise F, Di Donato A, Filippelli A. Antioxidant supplementation in the treatment of aging-associated diseases. Front Pharmacol. 2016;7:24. doi: 10.3389/fphar.2016.00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Park JK, Hong IH, Ki MR, Chung HY, Ishigami A, Ji AR, Goo MJ, Kim DH, Kwak JH, Min CW, Lee SS. Vitamin C deficiency increases the binucleation of hepatocytes in Smp30 knock-out mice. J Gastroenterol Hepatol. 2010;25:1769–1776. doi: 10.1111/j.1440-1746.2010.06239.x. [DOI] [PubMed] [Google Scholar]
- 23.Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022. doi: 10.1002/hep.24199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38:37–51. doi: 10.1111/j.1872-034X.2007.00216.x. [DOI] [PubMed] [Google Scholar]
- 25.El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–1273. doi: 10.1053/j.gastro.2011.12.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15:14–22. doi: 10.1634/theoncologist.2010-S4-14. [DOI] [PubMed] [Google Scholar]
- 27.Shirakami Y, Gottesman ME, Blaner WS. Diethylnitro-samine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration. Carcinogenesis. 2012;33:268–274. doi: 10.1093/carcin/bgr275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yang X, Bhaumik M, Bhattacharyya R, Gong S, Rogler CE, Stanley P. New evidence for an extra-hepatic role of N-acetylglucosaminyltransferaseⅢ in the progression of diethyl-nitrosamine-induced liver tumors I mice. Cancer Res. 2000;60:3313–3321. [PubMed] [Google Scholar]
- 29.Lee YS, KiM WH, Yu ES, Kin MR, Lee MJ, Jang JJ. Time course of cell cycle-related protein expression in diethyl-nitrosamine-initiated rat liver. J Hepatol. 1998;29:464–473. doi: 10.1016/s0168-8278(98)80066-4. [DOI] [PubMed] [Google Scholar]
- 30.Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, Kubo S, Akita M, Maruyama N. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun. 2004;315:575–580. doi: 10.1016/j.bbrc.2004.01.091. [DOI] [PubMed] [Google Scholar]
- 31.Aizawa S, Senda M, Harada A, Maruyama N, Ishida T, Aigaki T, Ishigami A, Senda T. Structural basis of the γ-lactone-ring formation in ascorbic acid biosynthesis by the senescence marker protein-30/gluconolactonase. PloS One. 2013;8:53706. doi: 10.1371/journal.pone.0053706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kondo Y, Masutomi H, Noda Y, Ozawa Y, Takahashi K, Handa S, Maruyama N, Shimizu T, Ishigami A. Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. FEBS open bio. 2014;4:522–532. doi: 10.1016/j.fob.2014.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Aumailley L, Warren A, Garand C, Dubois MJ, Paquet ER, Le Couteur DG, Marette A, Cogger VC, Lebel M. Vitamin C modulates the metabolic and cytokine profiles, alleviates hepatic endoplasmic reticulum stress, and increases the life span of Gulo−/− mice. Aging. 2016;8:458. doi: 10.18632/aging.100902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kishimoto Y, Kanai T, Sato K, Lee J, Jeong KS, Shimokado K, Maruyama N, Ishigami A. Insufficient ascorbic acid intake during gestation induces abnormal cardiac dilation in fetal and neonatal SMP30/GNL knockout mice. Pediatr Res. 2013;73:578–584. doi: 10.1038/pr.2013.22. [DOI] [PubMed] [Google Scholar]
- 35.Kim YJ, Kang KS, Yokozawa T. The anti-melanogenic effect of pycnogenol by its anti-oxidative actions. Food Chem Toxicol. 2008;46:2466–2471. doi: 10.1016/j.fct.2008.04.002. [DOI] [PubMed] [Google Scholar]
- 36.Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Roman-Franco A. Orthomolecular oncology reviw: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005;4:32–44. doi: 10.1177/1534735404273861. [DOI] [PubMed] [Google Scholar]
- 37.Shekelle P, Hardy ML, Coulter I, Udani J, Spar M, Oda K, Jungvig LK, Tu W, Suttorp MJ, Valentine D, Ramirez L, Shanman R, Newberry SJ. Effect of the supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer. Evid Rep Technol Assess. 2003;75:1–3. [PMC free article] [PubMed] [Google Scholar]
- 38.Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, Wagner EF. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell. 2003;112:181–192. doi: 10.1016/s0092-8674(03)00042-4. [DOI] [PubMed] [Google Scholar]
- 39.Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–466. doi: 10.1038/nature02924. [DOI] [PubMed] [Google Scholar]
- 40.Pallauf K, Bendall JK, Scheiermann C, Watschinger K, Hoffmann J, Roeder T, Rimbach G. Vitamin C and lifespan in model organisms. Food Chem Toxicol. 2013;58:255–263. doi: 10.1016/j.fct.2013.04.046. [DOI] [PubMed] [Google Scholar]
- 41.Sadowska-Bartosz I, Bartosz G. Effect of antioxidants supplementation on aging and longevity. BioMed Res Int. 2014;2014:404680. doi: 10.1155/2014/404680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Harrison FE. A critical review of vitamin C for the prevention of age-related cognitivedecline and Alzheimer’s disease. J Alzheimers Dis. 2012;29:711–726. doi: 10.3233/JAD-2012-111853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sánchez-Pérez Y, Carrasco-Legleu C, García-Cuellar C, Pérez-Carreón J, Hernández-García S, Salcido-Neyoy M, Alemán-Lazarini L, Villa-Treviño S. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005;217:25–32. doi: 10.1016/j.canlet.2004.07.019. [DOI] [PubMed] [Google Scholar]
- 44.Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis. Toxicol Sci. 2002;67:322–328. doi: 10.1093/toxsci/67.2.322. [DOI] [PubMed] [Google Scholar]
- 45.Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, Malarkey DE, Kaufmann W, Küttler K, Deschl U, Nakae D. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol. 2010;38:5–81. doi: 10.1177/0192623310386499. [DOI] [PubMed] [Google Scholar]
- 46.Calvisi DF, Snorri S. Thorgeirsson. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Toxicol Pathol. 2005;33:181–184. doi: 10.1080/01926230590522095. [DOI] [PubMed] [Google Scholar]
- 47.Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Seminars in liver disease. Thieme Medical Publishers, Inc. 2005;25 doi: 10.1055/s-2005-871193. [DOI] [PubMed] [Google Scholar]
- 48.Zhu X, Siedlak SL, Wang Y, Perry G, Castellani RJ, Cohen ML, Smith MA. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol Appl Neurobiol. 2008;34:457–465. doi: 10.1111/j.1365-2990.2007.00908.x. [DOI] [PubMed] [Google Scholar]
- 49.Liu CM, Zheng GH, Ming QL, Chao C, Sun JM. Sesamin protects mouse liver against nickel-induced oxidative DNA damage and apoptosis by the PI3K-Akt pathway. J Agric Food Chem. 2013;61:1146–1154. doi: 10.1021/jf304562b. [DOI] [PubMed] [Google Scholar]
- 50.Mary VS, Arias SL, Otaiza SN, Velez PA, Rubinstein HR, Theumer MG. The aflatoxin B1-fumonisin B1 toxicity in BRL-3A hepatocytes is associated to induction of cytochrome P450 activity and arachidonic acid metabolism. Environ Toxicol. 2017;32:1711–1724. doi: 10.1002/tox.22395. [DOI] [PubMed] [Google Scholar]